Research Roundup: What we’re reading this week
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
The US Food and Drug Administration has announced it will give priority review to a new treatment for multi-drug resistant tuberculosis. The announcement came after the drugmaker applied to the European Medicines Agency for approval.
Nils Daulaire, director of the Office of Global Affairs at the US Department of Health and Human Services, writes about the agency’s first-ever global health strategy.
Reuters recently examined several scientific breakthroughs in HIV and AIDS in recent years, and how the global financial crisis could impact progress against the disease.
An article looks at how the US presidential candidates would handle foreign aid and international development if elected in November. A related piece examines the social, political, and financial issues at play ahead of the presidential election and their implications for domestic and global health programs.